pI: 7.1801 |
Length (AA): 212 |
MW (Da): 25208 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | Trophozoite, Rahman HM-1 IMSS Trophozoite. | Hon CC |
Hon CC | Transcriptomics of virulent and avirulent strains |
Ortholog group members (OG5_128044)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G55810 | bifunctional nicotinamide mononucleotide adenyltransferase and nicotinate-nucleotide adenylyltransferase |
Brugia malayi | Bm1_39780 | Chain A, Crystal Structure Of NmnNAMN ADENYLYLTRANSFERASE COMPLEXED With Nad. |
Brugia malayi | Bm1_36205 | Cytidylyltransferase family protein |
Candida albicans | CaO19.7499 | similar to S. cerevisiae YLR328W |
Caenorhabditis elegans | CELE_F26H9.4 | Protein NMAT-2 |
Caenorhabditis elegans | CELE_W06B3.1 | Protein NMAT-1 |
Dictyostelium discoideum | DDB_G0288757 | nicotinamide-nucleotide adenylyltransferase |
Drosophila melanogaster | Dmel_CG13645 | Nicotinamide mononucleotide adenylyltransferase |
Echinococcus granulosus | EgrG_001062300 | nicotinamide mononucleotide adenylyltransferase |
Entamoeba histolytica | EHI_084990 | nicotinamide nucleotide adenylyltransferase, putative |
Entamoeba histolytica | EHI_010950 | NMN adenylyltransferase, putative |
Echinococcus multilocularis | EmuJ_001062300 | nicotinamide mononucleotide adenylyltransferase |
Giardia lamblia | GL50803_92618 | Nicotinamide-nucleotide adenylyltransferase |
Giardia lamblia | GL50803_13672 | Nicotinamide-nucleotide adenylyltransferase |
Homo sapiens | ENSG00000163864 | nicotinamide nucleotide adenylyltransferase 3 |
Homo sapiens | ENSG00000173614 | nicotinamide nucleotide adenylyltransferase 1 |
Leishmania braziliensis | LbrM.17.1470 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_171450.1 | cytidylyltransferase, putative |
Leishmania infantum | LinJ.17.1450 | hypothetical protein, conserved |
Leishmania major | LmjF.17.1340 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.17.1340 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_01131 | cytidylyltransferase |
Loa Loa (eye worm) | LOAG_00727 | hypothetical protein |
Mus musculus | ENSMUSG00000032456 | nicotinamide nucleotide adenylyltransferase 3 |
Mus musculus | ENSMUSG00000046402 | retinol binding protein 1, cellular |
Mus musculus | ENSMUSG00000028992 | nicotinamide nucleotide adenylyltransferase 1 |
Oryza sativa | 4331124 | Os02g0814900 |
Onchocerca volvulus | OVOC535 | Nicotinamide mononucleotide adenylyltransferase 2 homolog |
Onchocerca volvulus | OVOC5082 | Nicotinamide mononucleotide adenylyltransferase 2 homolog |
Saccharomyces cerevisiae | YGR010W | nicotinamide-nucleotide adenylyltransferase NMA2 |
Saccharomyces cerevisiae | YLR328W | nicotinamide-nucleotide adenylyltransferase NMA1 |
Schistosoma mansoni | Smp_123490 | nicotinamide mononucleotide adenylyltransferase |
Schmidtea mediterranea | mk4.008055.00 | Nicotinamide mononucleotide adenylyltransferase 2 |
Trypanosoma brucei gambiense | Tbg972.5.3720 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.5.2640 | nicotinamide/nicotinic acid mononucleotide adenylyltransferase |
Trypanosoma congolense | TcIL3000_5_2680 | hypothetical protein, conserved |
Trypanosoma congolense | TcIL3000_5_2590 | cytidylyltransferase, putative |
Trypanosoma cruzi | TcCLB.507047.170 | cytidylyltransferase, putative |
Trypanosoma cruzi | TcCLB.509179.80 | cytidylyltransferase, putative |
Trichomonas vaginalis | TVAG_110480 | nicotinamide mononucleotide adenylyltransferase, putative |
Trichomonas vaginalis | TVAG_072070 | nicotinamide mononucleotide adenylyltransferase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.5.2640 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.5.2640 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.5.2640 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.5.2640 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F26H9.4 | Caenorhabditis elegans | embryonic lethal | wormbase |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Bacillus anthracis | Nicotinate-nucleotide adenylyltransferase | 189 aa | 22.6% | 208 aa | Compounds | References |
Staphylococcus aureus (strain N315) | Probable nicotinate-nucleotide adenylyltransferase | 189 aa | 24.5% | 204 aa | Compounds | References |